AddLife ABSTU:1AD1 -0.07%88 OCF Yield % is 6.06 as of Jul. 08, 2026, which is 30% above its 10-year median of 4.67. GuruFocus rates STU:1AD1 with a GF Score™ of 88/100 and a GF Value™ of €13.31. The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, AddLife AB ranks better than 71.6% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for AddLife AB's OCF Yield % or its related term are showing as below:
STU:1AD1'
s OCF Yield % Range Over the Past 10 Years
Min: 2.14 Med: 4.67 Max: 9.49
Current: 6.06
During the past 13 years, the highest OCF Yield % of AddLife AB was 9.49%. The lowest was 2.14%. And the median was 4.67%.
STU:1AD1's OCF Yield % is ranked better than 71.6% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.71
vs STU:1AD1: 6.06
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AddLife AB OCF Yield % Related Terms
AddLife AB OCF Yield % Historical Data
* Premium members only.
The historical data trend for AddLife AB's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:1AD1 vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, AddLife AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's OCF Yield % distribution charts can be found below:
* The bar in red indicates where AddLife AB's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AddLife AB (STU:1AD1) has a OCF Yield % of 6.06 as of Jul. 08, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AddLife AB and its competitors. This is 30% above median its historical median of 4.67. Over the past decade, AddLife AB's OCF Yield % has ranged from 2.14 to 9.49. According to the industry distribution chart, AddLife AB ranks #242 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 28.4%.
Is AddLife AB's OCF Yield % too high?
AddLife AB's current OCF Yield % of 6.06 is 30% above median its 10-year median of 4.67. Over the past 10 years, this metric has ranged from a low of 2.14 to a high of 9.49. The Medical Devices & Instruments industry median OCF Yield % is 1.71. AddLife AB's value of 6.06 is 254.4% above this industry median. Based on the distribution chart, AddLife AB ranks #242 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AddLife AB has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AddLife AB ranks #242 out of 852 companies for OCF Yield %. This puts AddLife AB in the upper half of its industry. The industry median OCF Yield % is 1.71. AddLife AB's value of 6.06 is 254.4% above this benchmark. Historically, AddLife AB's own OCF Yield % has ranged from 2.14 to 9.49 over the past decade. While the company's 10-year median is 4.67 vs. the industry median of 1.71, AddLife AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.71, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AddLife AB's current OCF Yield % of 6.06 is 254.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AddLife AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AddLife AB's current OCF Yield % is 6.06, which is 30% above median its own 10-year median of 4.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
AddLife AB (STU:1AD1) has a current OCF Yield % of 6.06. The stock's GF Value™ is €13.31, compared to a current price of €14.95 — trading 12.3% above its estimated fair value. The current OCF Yield % is 6.06, which is 30% above median its 10-year median of 4.67 and 254.4% above the Medical Devices & Instruments industry median of 1.71. AddLife AB's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For AddLife AB (STU:1AD1), the current OCF Yield % is 6.06 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AddLife AB (STU:1AD1) Overvalued in 2026?
Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued.
The current stock price of €14.95 is trading 12.3% above its estimated GF Value™ of €13.31.
Key valuation signals for STU:1AD1:
OCF Yield %: 6.06 (30% above median its 10-year median of 4.67)
GF Value™: €13.31 vs. price of €14.95 (12.3% above fair value)
Industry Position: 254.4% above the Medical Devices & Instruments median (#242 of 852)
No single metric tells the full story. See the STU:1AD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
88GF Score
Get the complete analysis for STU:1AD1
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1AD1 has been successfully added to your 
